Your session is about to expire
← Back to Search
This trial is important because it will help doctors understand how to best treat brain tumors by looking at their molecular features. Sonobiopsy has the potential to become a standard tool for diagnosing and managing brain tumors, which could dramatically improve patient outcomes.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You cannot undergo a magnetic resonance imaging (MRI) scan.You have had surgery on your head in the past.You have had cancer before and received treatment for it.You have a scalp or skin condition that prevents the ultrasound probe from making contact.You have a physical defect in your skull.You are already taking part in another clinical trial that involves receiving treatment before surgery.The abnormality being studied must be located in the upper part of the brain and within 5 cm of the outer layer.
- Group 1: Sonobiopsy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently taking part in this research study?
"Affirmative. The clinicaltrial.gov registry states that this research program is actively seeking participants and was first listed on April 16th 2022. To date, the trial has enrolled 20 individuals at a single medical center."
Is enrollment in this experiment ongoing?
"Confirmation of active recruitment is available on clinicaltrials.gov; this trial was initially made public on April 16th 2022 and the most recent update occurred September 21st of the same year."
Share this study with friends